Skip to main content
. Author manuscript; available in PMC: 2019 Dec 11.
Published in final edited form as: Clin Gastroenterol Hepatol. 2015 Feb 11;13(9):1616–1624. doi: 10.1016/j.cgh.2015.02.005

Table 1.

Resistance Pattern in H pylori Strains Isolated in Male Patients During 2009 to 2013

Total All N = 128 Untreated patients N = 110
All susceptible 65 (50.8%) 60 (54.5%)
Mono resistance 41 (32.0%) 34 (30.9%)
Clarithromycin resistance only 6 (4.7%) 6 (5.5%)
Metronidazole resistance only 13 (10.2%) 9 (8.2%)
Levofloxacin resistance only 21 (16.4%) 18 (16.4%)
Tetracycline resistance only 1 (0.8%) 1 (0.9%)
Multiple resistance 22 (17.2%) 16 (14.5%)
Clarithromycin + metronidazole 3 (2.3%) 2 (1.8%)
Clarithromycin + levofloxacin 9 (7.0%) 6 (5.5%)
Metronidazole + levofloxacin 7 (5.5%) 6 (5.5%)
Clarithromycin + metronidazole + levofloxacin 3 (2.3%) 2 (1.8%)